T(2,8) VARIANT TRANSLOCATION IN BURKITTS-LYMPHOMA - MAPPING OF CHROMOSOMAL BREAKPOINTS BY INSITU HYBRIDIZATION

被引:4
作者
ADOLPH, S
HAMEISTER, H
HENGLEIN, B
LIPP, M
HARTL, P
BAAS, F
LENOIR, G
BORNKAMM, GW
机构
[1] UNIV FREIBURG KLINIKUM,INST MED MIKROBIOL & HYG,VIROL ABT,D-7800 FREIBURG,FED REP GER
[2] UNIV MUNICH,INST BIOCHEM,D-8000 MUNICH 2,FED REP GER
[3] ACAD ZIEKENHUIS AMSTERDAM,AMSTERDAM,NETHERLANDS
[4] INT AGCY CANC RES,F-69732 LYONS,FRANCE
关键词
D O I
10.1002/ijc.2910440213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:261 / 265
页数:5
相关论文
共 38 条
[1]  
BAAS F, 1985, HUM GENET, V69, P139
[2]   A BLOCK TO ELONGATION IS LARGELY RESPONSIBLE FOR DECREASED TRANSCRIPTION OF C-MYC IN DIFFERENTIATED HL60 CELLS [J].
BENTLEY, DL ;
GROUDINE, M .
NATURE, 1986, 321 (6071) :702-706
[3]  
BORNKAMM GW, 1988, CELLULAR ONCOGENE AC, P223
[4]   MUTATIONS IN THE 1ST EXON ARE ASSOCIATED WITH ALTERED TRANSCRIPTION OF C-MYC IN BURKITT-LYMPHOMA [J].
CESARMAN, E ;
DALLAFAVERA, R ;
BENTLEY, D ;
GROUDINE, M .
SCIENCE, 1987, 238 (4831) :1272-1275
[5]   VARIANT (6-15) TRANSLOCATIONS IN MURINE PLASMACYTOMAS INVOLVE A CHROMOSOME-15 LOCUS AT LEAST 72 KB FROM THE C-MYC ONCOGENE [J].
CORY, S ;
GRAHAM, M ;
WEBB, E ;
CORCORAN, L ;
ADAMS, JM .
EMBO JOURNAL, 1985, 4 (03) :675-681
[6]  
CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6
[7]   BURKITT-LYMPHOMA CELL-LINE CARRYING A VARIANT TRANSLOCATION CREATES NEW DNA AT THE BREAKPOINT AND VIOLATES THE HIERARCHY OF IMMUNOGLOBULIN GENE REARRANGEMENT [J].
DENNY, CT ;
HOLLIS, GF ;
MAGRATH, IT ;
KIRSCH, IR .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (11) :3199-3207
[8]   TRANSCRIPTIONAL ARREST WITHIN THE 1ST EXON IS A FAST CONTROL MECHANISM IN C-MYC GENE-EXPRESSION [J].
EICK, D ;
BORNKAMM, GW .
NUCLEIC ACIDS RESEARCH, 1986, 14 (21) :8331-8346
[9]   ABERRANT C-MYC RNAS OF BURKITT-LYMPHOMA CELLS HAVE LONGER HALF-LIVES [J].
EICK, D ;
PIECHACZYK, M ;
HENGLEIN, B ;
BLANCHARD, JM ;
TRAUB, B ;
KOFLER, E ;
WIEST, S ;
LENOIR, GM ;
BORNKAMM, GW .
EMBO JOURNAL, 1985, 4 (13B) :3717-3725
[10]  
EICK D, 1988, ONCOGENE, V3, P397